True North BioPharm, LLC is a woman-owned firm that operates as a highly specialized and tailored provider of consulting services to clients in the medical countermeasure (MCM) ecosystem. True North BioPharm’s core services are designed to provide tailored solutions and insights that meet the specific needs of our clients and help them achieve their goals. The firm has the experience and expertise to independently evaluate product portfolios, identify areas of alignment with current and future federal funding opportunities, and coordinate the pursuit, capture, and management of non-dilutive resources to support MCM development for known and unknown threats. True North BioPharm is experienced in capturing and managing federal contracts and research grants from the National Institutes of Health (NIH), Biomedical Advanced Research and Development Authority (BARDA), Department of Defense (DoD), National Cancer Institute (NCI), and other key U.S. agencies.

True North BioPharm takes a practical, hands-on approach to support host-directed, threat agnostic MCM development programs. Consultants seamless embed into client teams to guide decisions on model selection and performer identification, advise on study design and protocol development, provide expert data review and interpretation, and support regulatory affairs. As needed, True North BioPharm draws on its extensive networks within the MCM ecosystem from nonclinical experts and regulatory advisors to physician scientists and grants administrators to assemble teams with the right expertise at the right time to lower costs and improve efficiency of the MCM development process.

Key areas of interest include chemical, biological, radiological, and nuclear (CBRN) countermeasures, emerging infectious diseases (e.g., viral hemorrhagic disease), and critical care, including trauma, sepsis, and acute respiratory distress syndrome.